Page last updated: 2024-11-03

prazosin and Gastric Diseases

prazosin has been researched along with Gastric Diseases in 2 studies

Prazosin: A selective adrenergic alpha-1 antagonist used in the treatment of HEART FAILURE; HYPERTENSION; PHEOCHROMOCYTOMA; RAYNAUD DISEASE; PROSTATIC HYPERTROPHY; and URINARY RETENTION.
prazosin : A member of the class of piperazines that is piperazine substituted by a furan-2-ylcarbonyl group and a 4-amino-6,7-dimethoxyquinazolin-2-yl group at positions 1 and 4 respectively.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hsu, DZ1
Wang, ST1
Deng, JF1
Liu, MY1
Bhandare, PN1
Rataboli, PV1
Diniz D'Souza, RS1
Dhume, VG1

Other Studies

2 other studies available for prazosin and Gastric Diseases

ArticleYear
Epinephrine protects against severe acute gastric bleeding in rats: role of nitric oxide and glutathione.
    Shock (Augusta, Ga.), 2005, Volume: 23, Issue:3

    Topics: Adrenergic alpha-Agonists; Animals; Blood Pressure; Enzyme Inhibitors; Epinephrine; Gastric Mucosa;

2005
Aggravating action of hydralazine on ethanol-induced gastric lesions.
    Indian journal of physiology and pharmacology, 1992, Volume: 36, Issue:2

    Topics: Animals; Captopril; Drug Interactions; Ethanol; Gastrointestinal Hemorrhage; Hydralazine; Male; Praz

1992